Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0023 | 0.0627 | 0.0627 |
Loa Loa (eye worm) | RNA binding protein | 0.0125 | 0.668 | 0.8433 |
Brugia malayi | TAR-binding protein | 0.0125 | 0.668 | 0.8433 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0018 | 0.0362 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.1397 | 1 |
Plasmodium vivax | enoyl-acyl carrier protein reductase | 0.0181 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.668 | 1 |
Echinococcus multilocularis | lamin | 0.0026 | 0.0835 | 0.1054 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0.0362 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.4087 | 0.5159 |
Brugia malayi | RNA binding protein | 0.0125 | 0.668 | 0.8433 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0018 | 0.0362 | 0.5776 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase superfamily protein | 0.0023 | 0.0627 | 0.0627 |
Mycobacterium ulcerans | enoyl-(acyl carrier protein) reductase | 0.0181 | 1 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0023 | 0.0627 | 0.0627 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.668 | 1 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.0081 | 0.4087 | 0.5159 |
Loa Loa (eye worm) | TAR-binding protein | 0.0125 | 0.668 | 0.8433 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.1397 | 0.2092 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.7921 | 1 |
Brugia malayi | hypothetical protein | 0.0036 | 0.1397 | 0.1764 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0018 | 0.0362 | 0.2593 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0018 | 0.0362 | 0.0362 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 0.0835 | 0.1054 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.668 | 1 |
Echinococcus granulosus | lamin dm0 | 0.0026 | 0.0835 | 0.1054 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.668 | 1 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.011 | 0.0139 |
Schistosoma mansoni | lamin | 0.0026 | 0.0835 | 0.125 |
Brugia malayi | intermediate filament protein | 0.0026 | 0.0835 | 0.1054 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.1397 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0018 | 0.0362 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0023 | 0.0627 | 0.0627 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0014 | 0.011 | 0.0139 |
Echinococcus granulosus | muscleblind protein | 0.0146 | 0.7921 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.668 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0806 | 0.1018 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.1397 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0.0362 | 0.0362 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.0013 | 0.0027 | 0.0034 |
Schistosoma mansoni | intermediate filament proteins | 0.0026 | 0.0835 | 0.125 |
Toxoplasma gondii | enoyl-acyl carrier reductase ENR | 0.0181 | 1 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0018 | 0.0362 | 0.0457 |
Wolbachia endosymbiont of Brugia malayi | enoyl-ACP reductase | 0.0181 | 1 | 1 |
Plasmodium falciparum | enoyl-acyl carrier reductase | 0.0181 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.7921 | 1 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.0081 | 0.4087 | 0.6118 |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.0013 | 0.0027 | 0.0034 |
Mycobacterium ulcerans | 4'-phosphopantetheinyl transferase | 0.0023 | 0.0627 | 0.0627 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0036 | 0.1397 | 0.1764 |
Schistosoma mansoni | ap endonuclease | 0.0018 | 0.0362 | 0.0542 |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 0.0835 | 0.1054 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 0.0835 | 0.1054 |
Onchocerca volvulus | 0.0026 | 0.0835 | 0.2043 | |
Mycobacterium ulcerans | phosphopantetheinyl transferase, PptII | 0.0023 | 0.0627 | 0.0627 |
Onchocerca volvulus | 0.0026 | 0.0835 | 0.2043 | |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0018 | 0.0362 | 0.0457 |
Echinococcus multilocularis | muscleblind protein | 0.0146 | 0.7921 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0125 | 0.668 | 0.8433 |
Toxoplasma gondii | exonuclease III APE | 0.0018 | 0.0362 | 0.0362 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0018 | 0.0362 | 0.0362 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase domain-containing protein | 0.0023 | 0.0627 | 0.0627 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.0081 | 0.4087 | 0.5159 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0.0362 | 0.0362 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0835 | 0.1054 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.1397 | 0.2092 |
Mycobacterium tuberculosis | NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) | 0.0181 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0627 | 0.449 |
Plasmodium vivax | holo-[acyl-carrier-protein] synthase, putative | 0.0023 | 0.0627 | 0.0627 |
Echinococcus multilocularis | tar DNA binding protein | 0.0125 | 0.668 | 0.8433 |
Echinococcus multilocularis | musashi | 0.0026 | 0.0835 | 0.1054 |
Brugia malayi | Muscleblind-like protein | 0.0146 | 0.7921 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 0.0835 | 0.1054 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 0.0835 | 0.1054 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0023 | 0.0627 | 1 |
Schistosoma mansoni | lamin | 0.0026 | 0.0835 | 0.125 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0023 | 0.0627 | 0.0627 |
Onchocerca volvulus | 0.0081 | 0.4087 | 1 | |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0023 | 0.0627 | 0.0627 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0146 | 0.7921 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0027 | 0.0034 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0036 | 0.1397 | 0.1764 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.0081 | 0.4087 | 0.5159 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0023 | 0.0627 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0018 | 0.0362 | 0.0457 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0125 | 0.668 | 0.8433 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.1397 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0018 | 0.0362 | 0.0457 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0023 | 0.0627 | 1 |
Mycobacterium leprae | NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) | 0.0181 | 1 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0125 | 0.668 | 0.8433 |
Trichomonas vaginalis | hypothetical protein | 0.0181 | 1 | 1 |
Echinococcus granulosus | lamin | 0.0026 | 0.0835 | 0.1054 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0.0362 | 0.0362 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0.0362 | 0.5776 |
Schistosoma mansoni | ap endonuclease | 0.0018 | 0.0362 | 0.0542 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.